Search For "emergency use listing"
WHO to give approval to Covaxin this month, say top health experts
Updated : 4 years, 5 months ago IST
New Delhi [India], October 2 (ANI): The decision on Bharat Biotech's Covid-19 vaccine, Covaxin Emergency Use Listing (EUL) by the World Health Organisation (WHO) is expected in October, informed the top health experts in the country on Saturday.
Read More
AIIMS Delhi Director hopes for early approval of COVID-19 vaccine Covaxin
Updated : 4 years, 5 months ago IST
New Delhi [India], October 1 (ANI): With the data and studies regarding COVID-19 vaccine Covaxin submitted to the World Health Organization, All India Institute of Medical Sciences (AIIMS) Delhi Director Randeep Guleria is hopeful that the authorisation for emergency use listing to the vacci
Read More
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): The World Health Organisation (WHO) on Wednesday informed that the final decision on Bharat Biotech's submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.
Read More
Bharat Biotech awaits feedback from WHO for COVID-19 vaccine Covaxin's eme
Updated : 4 years, 5 months ago IST
New Delhi [India], September 17 (ANI): Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.
Read More
Close to a decision point, says Dr V K Paul on WHO Emergency Use Listing t
Updated : 4 years, 6 months ago IST
New Delhi [India], September 14 (ANI): The approval of Bharat Biotech's COVID-19 vaccine Covaxin for Emergency use Listing (EUL) from the World Health Organisation (WHO) is expected at any time soon, said Dr VK Paul, NITI Aayog member (Health) on Tuesday.
Read More
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
Updated : 4 years, 7 months ago IST
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poonam Kh
Read More
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global bod
Read More
EUL to Covaxin from WHO expected in first week of August: Sources
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by
Updated : 4 years, 9 months ago IST
New Delhi [India], May 26 (ANI): COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Septembe
Read More
Bharat Biotech submits 90 pc documentation, confident of WHO emergency use
Updated : 4 years, 9 months ago IST
New Delhi [India], May 24 (ANI): Bharat Biotech is confident about obtaining the World Health Organization's (WHO) Emergency Use Listing for its COVID-19 vaccine given its experience of getting its other vaccines pre-qualified and has submitted 90 per cent of the documentation required for E
Read More
Centre issues regulatory pathways for foreign-produced COVID-19 vaccines
Updated : 4 years, 11 months ago IST
New Delhi [India], April 15 (ANI): In view of the rapid surge in coronavirus cases in India, the Central government approved a significant streamlining and fast-tracking of the regulatory system for COVID-19 vaccines approved for restricted use by US FDA, EMA, UK MHRA, PMDA Japan or which ar
Read More